|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
CHI's GENOMICS ON TARGET: From Function to Validation | ||||||||||||||||
June 04, 2002 | ||||||||||||||||
Cambridge Heathtech Institute, Boston, Massachusetts November 18-21, 2002 Cambridge Healthtech Institute (CHI) is pleased to offer GENOMICS ON TARGET: From Function to Validation, November 18-21, 2002 at The Sheraton Hotel in Boston, Massachusetts. This event provides access to four highly successful CHI conferences: November 18-19 Functional Genomics | Chemical Genomics/Chemogenomics November 20-21 Animal Models | High-Throughput Target Validation Delegates may choose to attend one of two conferences over a two day period, or stay for all four days and listen to talks from any of the four offerings. Researchers and business professionals focused on early-stage drug discovery will find GENOMICS ON TARGET offers exceptional value in a time saving format. In four days choose from more than 80 talks and learn everything you need to know about genes and targets. |
||||||||||||||||
Organized by: | CHI | |||||||||||||||
Invited Speakers: | Dr. Dalia Cohen, Novartis Pharmaceuticals Corp. Dr. Steven H. Holzmann, Infinity Pharmaceuticals, Inc. Dr. Gregory A. Petsko, Brandeis University Dr. Michael Snyder, Yale University Dr. Robert L. Strausberg, National Cancer Institute Dr. Marc Vidal, Dana Farber Cancer Institute |
|||||||||||||||
Deadline for Abstracts: | Poster abstracts: October 11, 2002 | |||||||||||||||
Registration: | Available on-line | |||||||||||||||
E-mail: | jlaakso@healthtech.com | |||||||||||||||
Posted by: | Jennifer Laakso | |||||||||||||||
Host: | wks217.healthtech.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |